HuagongsheHuagongshe Chemistry Print Report · For research reference only
Lorazepam → 1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Lorazepam | HCID 3958 | — |
| Catalyst | Benzyl triethylammonium chloride | HCID 66133 | — |
| Solvent | Acrylonitrile | HCID 7855 | — |
| Product | 1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one | HCID 10317256 | — |
Reaction Steps
1 g of Teba and 8 drops of a 40% methanolic solution of Triton B were added to a suspension of 10 g of 7-chloro-3-hydroxy-5-(2'-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one ("Lorazepam") in 50 ml of acrylonitrile and the mixture was stirred for 24 hours at room temperature. Then the reaction mixture was cooled to 4° C., the precipitate was filtered and recrystallized from ethyl acetate. 1-(2-Cyanoethyl)-7-chloro-3-hydroxy-5-(2'-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one, m.p. 198° to 202° C., was obtained. Without addition of Teba also the disubstituted 1-(2-cyanoethyl)-7-chloro-3-(2-cyanoethoxy)-5-(2'-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepine-2-one, m.p. 210° to 213° C. (from acetonitrile), is obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US04388313 |
| Source dataset | uspto-grants-1983_06 |
| ORD ID | ord-d4d29dc6bfde473fb2b3a8558eb506ee |
| Source note | uspto-grants-1983_06 |